(Received for publication February 20, 1996) Thirty analogues of poststatin were synthesized, and their inhibitory activities against prolyl endopeptidase, humanleukocyte elastase and cathepsin B were measured. The a-ketone was essential and the S configuration was preferable to the R configuration in the /?-substituted-/?-amino-aoxopropionic acid moiety ofpoststatin analogues for endopeptidase inhibitory activity. The analogue in which the D-leucine residue of poststatin was replaced by L-leucine showed strong inhibitory activity to cathepsin B. Introduction of an aromatic group into the P4 position and proline into the P2 position increased inhibitory activity to elastase. Benzyloxycarbonyl-L-homophenylalanyl-(i?S> 3-amino-2-oxovaleryl-D-leucyl-L-valine was about 6 times more active to prolyl endopeptidase than natural poststatin. The absolute configuration of the 3-amino-2-oxovaleric acid (named as postine, abbreviated as Pos) moiety was established to be S.3) Total synthesis of PST was achieved by both conventional liquid phase peptide synthesis and solid phase synthesis using (2i?,3S)-3-amino-2-hydroxyvaleric acid4). Because prolyl endopeptidase is a serine endopeptidase, prolinecontaining chloromethyl ketone derivatives or peptide aldehyde analogues such as benzyloxycarbonyl (abbreviated as Z)-Gly-Pro-CH2C1 or Z-Pro-prolinal were designed, synthesized, and found to show strong inhibitory activity to this enzyme by Yoshimoto in 19775) and Wilk in 19836) . In comparison with these compounds, PST contains a unique amino acid, Pos, and includes neither pyrrolidine nor aldehyde groups in its structure. Moreover, PST has D-Leu-Val at the P^and P2 position in its structure, which could be modified or replaced with another suitable structure for the subsite of individual target endopeptidase. In this paper, we report information on the relationship between structure and inhibitory activity to three enzymes, PEP, humanleukocyte elastase and cathepsin B, as representatives of serine and cysteine proteinases. SEPT. 1996 Chemistry Poststatin analogues were prepared by the following methods. Liquid phase method A consists of temporary protection by acid sensitive groups (Boc, Z(OMe) ) and final deprotection by hydrogenolysis. Liquid phase method B consists of temporary protection by hydrogenation sensitive groups (Z, Z(OMe)) and final deprotection by acid treatment. In both liquid phase methods oxidation of hydroxyl group to ketone was performed by the Pfitzner-Moffatt method7). In the solid phase method, Fmoc-strategy with alkoxybenzylester resin was adopted, and the oxidation was performed by the Albright-Goldman method8).
Structure-activity Relationship
Structures and inhibitory activities are summarizedin Table 1 . Replacement of Pos moiety by (S)-2-aminobutyric acid (2) or (2RS,3S)-3-amino-2-hydroxyvaleric acid (3) decreased the inhibitory activity to three enzymes drastically.
The epimer of the Pos moiety (4) is only about a sixteenth as active as PST for PEP. Replacement of the ethyl side chain of the postine moiety with Me (5), Pr (6) or benzyl (7) suggests that a Me or Et side chain is preferable for PEP inhibition. The analogues 8 and 9 having Me or Et side chain with Z group at the TV-terminal showed almost the same inhibitory activity to PEP. These data suggest that a-ketone is essential to inhibitory activity, the S configuration of the Pos moiety is important and a Meor Et side chain in the postine moiety is preferable for anti-PEP activity.
The presence of a D-amino acid just after the postine moiety is significant.
Analogues 10, ll and 12, in which D-Leu is replaced by L-Leu or Gly, showed weak inhibitory activity to PEP but strong inhibitory activity to cathepsin B. Therefore, the d configuration is essential for good anti-PEP activity and the l configuration or Gly is preferable for anti-cathepsin B activity. Although PST shows weak inhibition of elastase, the resemblance of postine to alanine suggests that some Therefore, the presence of some residue at the P2 position is preferable, but it is not necessary that it be an amino acid.
Conclusion
The^substituted-j6-amino-a-oxo-acid moiety of poststatin is essential for the inhibition of serine and cysteine proteinases. Size and stereochemistry of jS-substituent is also important for these activities. By comparison of the inhibitory activities to three enzyme, it was demonstrated that the selectivity and magnitude of the inhibitory activity can be modulated by replacement of the jS-alkylsubstituent of postine and the P3-P2 and P^-Pâ mino acids.
Experimental

General Method
Melting points were determined on a micro melting point apparatus and are uncorrected. Optical rotations were measured with a Perkin-Elmer 241 polarimeter. XH NMRspectra were recorded at 400MHzor 270MHz with a JEOL JNM-GX400 or a JNM-EX270 spectrometer respectively. SI-MS or FAB-MSspectra were measured on a Hitachi M-80H or a JEOL JMS-SX102 operating at 254nm and Model FCU-V injector. The two phase solvent system composed of 1-BuOH-AcOH-H2O (500 : 3 : 500) was equilibrated in a separatory funnel at room temperature and the layers separated before use. The upper layer was used as stationary phase and the lower layer was used as mobile phase in descending mode.
Abbreviations used in the following section were defined in the above section and Table 1 .
Synthesiŝ
-Substituted-j5-amino-a-hydroxypropionic Acid 3-Amino-2-hydroxybutyric acid (32) and 3-amino-2-hydroxyhexanoic acid (33) were obtained by an analogous procedure to that described for the preparation of 3-amino-2-hydroxyvaleric acid (H2Pos three equivalent of 1 -hydroxybenzotriazole (abbreviated as HOBt) and three equivalent of diisopropylcarbodiimide were used. To the resultant Boc-or Z-penta (or tetra)peptide resin was added acetic anhydride (0.4ml) and pyridinium trifluoroacetate (106mg) in DMSO (6ml), and the mixture was stirred overnight. The oxidized peptide resin was washed with DMSO(6.5 ml), VOL.49 NO.9 THE JOURNAL OF ANTIBIOTICS thrice with DMF(each 6.5ml), and thrice with MeOH (each 6.5 ml) and dried over P2O5. To liberate the peptide from the resin, the resin was stirred in TFA(6.5ml) containing 5% (w/v) phenol for 1 hour, and the resin particles removed by filtration. This operation was carried out again, and the resin was washed thrice with TFA (6.5 ml). 
Phe-Pos) + 2H) MSdata and Rfvalues for these synthetic compounds and the following analogues of PST synthesized by the liquid phase method are shown in Table 2 . (1.033 g, 5.39mmol) under ice cooling, and the mixture was stirred in an ice bath for 2 hours and at room temperature for 6 hours. The mixture was diluted with EtOAc (50 ml) and washed with 4% aq NaHCO3 (40 ml), saturated aq NaCl (20ml), 1% aq citric acid (20ml) and saturated aq NaCl (20ml), and dried (Na2SO4). After removal of the solvent, the product was purified by silica 
The starting L-homophenylalanine ethyl ester hydrochloride was derived from L-Hph which was prepared from DL-Hph according to the optical resolution procedure reported by Miyazawa et aL1X) To an ice-cold solution of L-homophenylalanine ethyl ester hydrochloride (1.22g, 5.01mmol) in CHC13 (10ml) was added triethylamine (1.54ml, ll.0mmol) and benzyl chloroformate (0.96 ml, 6.01 mmol), and the mixture was stirred for in an ice bath for 20 minutes and at room temperature for 2 hours. The mixture was washedwith
In HC1 (10ml) and saturated aq NaCl (10ml). Evaporation of the solvent gave Z-L-homophenylalanine ethyl ester as a solid. To an ice-cold solution of Z-L-homophenylalanine ethyl ester in MeOH(5ml) was added I n NaOH(5.5ml), and the mixture was stirred for 2 hours at roomtemperature. After evaporation of the solvent, water (10ml) was added and the mixture washed twice with ether (each 10ml). The mixture was acidified with I n HC1 (6.6ml), extracted thrice with AcOEt (each 10 ml) and the extract dried (Na2SO4). After removal of the solvent, the product was purified by silica 
To a solution of35 (329.7mg, 0.616mmol) in MeOH (3 ml) was added palladium-black catalyst (5.2 mg). The mixture was hydrogenated at room temperature in a hydrogen atmosphere for 26.5 hours. The catalyst was filtered off, and evaporation of the solvent gave (2i^3i?S>H2Pos-D-Leu-L-Val-OBuf (39; 247.1 mg, 0.615mmol).
To 39 (150.2mg, 0.374mmol) was added SEPT. 1996 Z-L-Hph (128.9mg, 0.411 mmol) and HOBt (102.8mg, 0.761 mmol) in DMF(2ml). To the mixture was added EDCà" HC1 (100.4 mg, 0.524mmol) under ice cooling, and the mixture was stirred in an ice bath for 6 hours. The mixture was diluted with EtOAc (20 ml) and washed with 4% aq NaHCO3(12ml), water (8ml), 1% aq citric acid (8 ml) and saturated aq NaCl (8 ml) and dried (Na2SO4). Evaporation of the solvent gave 38, 259.8 mg (99.7%) as asolid: FAB-MSm/z697 (M+H)+, 641 (M-/Bu+H)+,
A mixture of 38 (259.8mg, 0.373mmol), pyridinium trifluoroacetate (36.9 mg, 0. 191 mmol), dicyclohexylcarbodiimide (abbreviated as DCC; 232.0 mg, 1.124mmol), anhydrous DMSO (2.0ml) and benzene (2.0ml) was stirred at room temperature for 6.5 hours. The reaction mixture was diluted with EtOAc (10ml), and the undissolved material was removed by filtration. The filtrate was washed with water (10 ml) and dried (Na2SO4). After evaporation of the solvent, the product was purified by silica gel column chromatography with CH2C12-MeOH (llH, m, Phx2, NH).
A solution of24 (209.2mg, 0.301 mmol) in TFA (3ml) was stirred at room temperature for 2 hours. The solution was evaporated, and the residue was coevaporated twice with toluene (each 2ml). The product was purified by silica gel column chromatography with CHC13-MeOHAcOH (600:5:2) to give 22 as an amorphous solid, 166.1 mg. This solid was chromatographed on a column of Sephadex LH-20 with MeOHelution. Evaporation of the active eluate gave 22 as an amorphous solid, 1 12.4mg (58.5%):
FAB-MS ( 97% EDC-HC1O4 (156.7mg, 0.594mmol) was added under ice cooling, and the mixture was stirred in an ice bath for 2 hours and at room temperature overnight. The mixture was diluted with CH2C12 (20 ml) and washed with 1% aq citric acid, water, saturated aq NaHCO3 and water (each 5 ml) and dried (Na2SO4 
